ir para o conteúdo principal
Logo Default

Centro Hospitalar de Leiria

Centro Hospitalar de Leiria

The Research Centre of Leiria Hospital Center E.P.E

The Research Centre (RC) of Leiria Hospital Center (LHC) E.P.E. is an organ that aims the promotion and coordination of all the studies and research projects in the various fields of knowledge, to be held in the LHC.
The RC's mission is to coordinate and streamline the implementation of the research activities at the institution, creating the necessary instruments to develop local projects and the establishment of partnerships with entities outside the LHC.

Our skills:

  • Organize, promote, monitor and disseminate studies and research projects carried out in the LHC and and also to implement and to maintain an updated database of the research projects, clinical trials, published papers, presentations, and questionnaires in the LHC, developed by LHC professionals as part of their qualification;
  • Validate and submit all clinical study and projects applications to the Administration Board and to the Local Ethics Committee (when applicable);
  • Support the clinical and non-clinical research teams in all administrative and logistical matters directly related, particularly as regards the financing of projects and external audits;
  • Support the clinical research teams in all the day-to-day research activities, including (but not limited to):
    - Prepare and support the conduction of study visits;
    - Perform data entry and query resolution;
    -‪‬ Feasibility management;
    - Support the process of documentation collection for study submissions.‬‬‬‬‬‬‬‬‬‬
  • Encouraging the establishment of research groups, conducting research projects and clinical trials;
  • Stimulate national and foreign institutional scientific cooperation.
  • proposalsto the Administration Board in order to establish protocols with external entities, aiming to support the research conducted at the institution;
  • Disclose external funding for scientific research to LHC research community and to support the applications. Are associate members of the RC, all integrated researchers, or not, in clinical and nonclinical teams or others research groups for studies or research projects underway in the CHL.

Year

Download
General Indicators
No. of active clinical studies by study type
  • 17
    Active Clinical Trials
  • 57
    Active Non-Interventional Studies
No. of initiated clinical studies by study type
  • 2
    Clinical Trials initiated
  • 49
    Non-Interventional Studies initiated
No. of active non-interventional clinical studies by therapeutic area
No. of active non-interventional clinical studies by sponsor type
No. of active Clinical trials by sponsor type
No. of active clinical trials per phase
No. of active clinical trials by trial object
No. of active clinical trials by therapeutic area
  • 64
    No. of publications in indexed journals - last 5 full years
  • 129
    No. of health professionals with specific training in GCP (Good Clinical Practices)
Global Capacity Indicators
  • 557
    No. of available beds in the institution
  • 409
    No. of Physicians in the Institution
  • 924
    No. of Nurses in the Institution
  • 13
    No. of Pharmacists in the Institution
  • 400.000
    No. of Inhabitants covered by the institution
HR Indicators Allocated to Research
Total number of people dedicated to clinical research in the institution
  • 129
    Researchers
  • 13
    Managers, Administrative, Legal and Financial
  • 3
    Study coordinators
  • 26
    Nurses
  • 8
    Pharmacists
Efficiency Indicators
  • 39
    Total number of participants recruited for clinical trials and interventional clinical studies of medical devices
  • N.A.
    Patient recruitment rate in clinical trials and interventional clinical studies of medical devices
  • N.A.
    Average time to first patient recruitment in clinical trials and interventional clinical studies of medical devices
  • N.A.
    Average time between submission and approval of the Financial Contract in clinical trials and interventional clinical studies of medical devices
General Indicators
No. of active clinical studies by study type
  • 22
    Active Clinical Trials
  • 58
    Active Non-Interventional Studies
No. of initiated clinical studies by study type
  • 5
    Clinical Trials initiated
  • 46
    Non-Interventional Studies initiated
No. of active non-interventional clinical studies by therapeutic area
No. of active non-interventional clinical studies by sponsor type
No. of active Clinical trials by sponsor type
No. of active clinical trials per phase
No. of active clinical trials by trial object
No. of active clinical trials by therapeutic area
  • N.A.
    No. of publications in indexed journals - last 5 full years
  • 129
    No. of health professionals with specific training in GCP (Good Clinical Practices)
Global Capacity Indicators
  • 516
    No. of available beds in the institution
  • 269
    No. of Physicians in the Institution
  • 921
    No. of Nurses in the Institution
  • 10
    No. of Pharmacists in the Institution
  • 400 thousand
    No. of Inhabitants covered by the institution
HR Indicators Allocated to Research
Total number of people dedicated to clinical research in the institution
  • 102
    Researchers
  • 13
    Managers, Administrative, Legal and Financial
  • 3
    Study coordinators
  • 27
    Nurses
  • 10
    Pharmacists
Efficiency Indicators
  • N.A.
    Total number of participants recruited for clinical trials and interventional clinical studies of medical devices
  • N.A.
    Patient recruitment rate in clinical trials and interventional clinical studies of medical devices
  • N.A.
    Average time to first patient recruitment in clinical trials and interventional clinical studies of medical devices
  • N.A.
    Average time between submission and approval of the Financial Contract in clinical trials and interventional clinical studies of medical devices

Clinical Research Areas of interest

Clinical Research Areas of interest

  • Oncology Disease - Antineoplastic and immunomodulatory drugs;
  • Autoimmune Diseases - Immunomodulatory drugs
  • Cardiovascular Diseases (Coronary Disease, Heart Failure and Cerebrovascular Disease) – Cardiovascular drugs;
  • Diabetes and Endocrine Diseases;
  • Neurological diseases (including dementias) – Medicines that act on the Central Nervous System;
  • Gastroenterological pathologies – Medicines for gastrointestinal, metabolic and immunomodulator indications;
  • Lysosomal Storage Disorders;
  • Respiratory diseases - Medicines that act on the respiratory system;
  • Infectious diseases – Anti-infectious drugs;
  • Hematopoietic medications;
  • Urological diseases;
  • Nephrological diseases;
  • Medical Devices;
  • Precision Medicine;
  • Translational and Regenerative Medicine;
  • Preventative Medicine and Healthy Aging:
  • Real World Evidence;
  • Artificial Intelligence.

Gallery

Hospital

Hospital

Latest News